Optimizing electrophilic 6-[18F]fluoro-L-DOPA synthesis utilizing low precursor concentration

被引：0
|
作者：
Arora, G. [1 ]
Shukla, J. [1 ]
Gupta, P. [1 ]
Bandopadhyaya, G. [1 ]
机构：
[1] All India Inst Med Sci, Delhi, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S493 / S493
页数：1
相关论文
共 50 条
  • [41] Blood platelets biokinetics of the neurotransmitter L-Dopamine using 6-[18F]-fluoro-L-Dopa
    Leitinger, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S622 - S622
  • [42] Rate of progression in Parkinson's disease:: A 6-[18F]fluoro-L-dopa PET study
    Nurmi, E
    Ruottinen, HM
    Bergman, J
    Haaparanta, M
    Solin, O
    Sonninen, P
    Rinne, JO
    MOVEMENT DISORDERS, 2001, 16 (04) : 608 - 615
  • [43] Personality traits and striatal 6-[18F]fluoro-L-dopa uptake in healthy elderly subjects
    Kaasinen, V
    Nurmi, E
    Bergman, J
    Solin, O
    Kurki, T
    Rinne, JO
    NEUROSCIENCE LETTERS, 2002, 332 (01) : 61 - 64
  • [44] Automated copper-mediated synthesis of 6-[18F]fluoro-L-DOPA using the Ora Neptis® Synthesizer
    Hienzsch, Antje
    Wolfrum, Anja
    Clemens, Anna
    Preshlock, Sean
    Verhoog, Stefan
    Gouverneur, Veronique
    Mollitor, Jan
    Hoepping, Alexander
    Mueller, Marco
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S477 - S477
  • [45] Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA
    Yee, RE
    Cheng, DW
    Huang, SC
    Namavari, M
    Satyamurthy, N
    Barrio, JR
    BIOCHEMICAL PHARMACOLOGY, 2001, 62 (10) : 1409 - 1415
  • [46] A reliable and automated synthesis of 6-[18F]fluoro-L-DOPA and the clinical application on the imaging of congenital hyperinsulinism of infants
    Zhang, Zhengwei
    Ge, Jingjie
    Jing, Kai
    Chen, Yefeng
    Guan, Yihui
    Xie, Hexin
    Zhu, Jianhua
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (07) : 1126 - 1134
  • [47] A reliable and automated synthesis of 6-[18F]fluoro-L-DOPA and the clinical application on the imaging of congenital hyperinsulinism of infants
    Zhengwei Zhang
    Jingjie Ge
    Kai Jing
    Yefeng Chen
    Yihui Guan
    Hexin Xie
    Jianhua Zhu
    Medicinal Chemistry Research, 2022, 31 : 1126 - 1134
  • [48] Aspects of 6-[18F]fluoro-L-DOPA preparation -: Deuterochloroform as a substitute solvent for Freon 11
    Fuechtner, F.
    Zessin, J.
    Maeding, P.
    Wuest, F.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (01): : 62 - 64
  • [49] A Dual-Tracer Study of Extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa Uptake in Parkinson's Disease
    Li, Clarence T.
    Palotti, Matthew
    Holden, James E.
    Oh, Jen
    Okonkwo, Ozioma
    Christian, Bradley T.
    Bendlin, Barbara B.
    Buyan-Dent, Laura
    Harding, Sandra J.
    Stone, Charles K.
    DeJesus, Onofre T.
    Nickles, Robert J.
    Gallagher, Catherine L.
    SYNAPSE, 2014, 68 (08) : 325 - 331
  • [50] A within-subject comparison of 6-[18F]Fluoro-m-Tyrosine (FMT) and 6-[18F]Fluoro-l-DOPA (FDOPA) in Parkinson disease (PD)
    Gallagher, Catherine L.
    Holden, James
    Christian, Brad
    Harding, Sandra
    Nickles, Robert J.
    Johnson, Sterling
    NEUROIMAGE, 2010, 52 : S75 - S75
12345